6.25
price down icon5.73%   -0.38
after-market After Hours: 6.56 0.31 +4.96%
loading

Olema Pharmaceuticals Inc Stock (OLMA) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
12.90%
34.34
30.42 23.34 21.60 29.60
Operating Income/Loss
12.90%
-34.34
-30.42 -23.34 -21.60 -29.60
Nonoperating Income/Loss
7.55%
3.369
3.644 1.84 1.506 1.316
Income/Loss From Continuing Operations Before Tax
15.69%
-30.97
-26.77 -21.50 -20.09 -28.29
Income/Loss From Continuing Operations After Tax
15.68%
-30.97
-26.77 -21.50 -20.09 -28.29
Net Income/Loss
15.68%
-30.97
-26.77 -21.50 -20.09 -28.29
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,611%
55.57
3.2471 44.98 40.72 40.35
Diluted Average Shares
1,611%
55.57
3.2471 44.98 40.72 40.35
Basic Earnings Per Share
16.67%
-0.56
-0.48 -0.48 -0.49 -0.70
Diluted Earnings Per Share
16.67%
-0.56
-0.48 -0.48 -0.49 -0.69
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):